QT Imaging Holdings Delivers Its Breast Imaging Scanner to Innovative Radiology in Des Moines, Iowa

NOVATO, Calif.--(BUSINESS WIRE)-- QT Imaging Holdings, Inc. (OTCQB:QTIH) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is proud to announce the delivery and installation of its QT Imaging Breast Acoustic CT™ Scanner at Innovative Radiology, led by Dr. John Tentinger in Des Moines, Iowa.

This installation brings QT Imaging’s radiation-free, 3D breast imaging technology to patients in Iowa for the first time. QT Imaging’s breast imaging scanner uses proprietary low-frequency ultrasound to generate high-resolution, 3D images of breast tissue—without ionizing radiation or compression. This non-invasive approach provides a safer, more comfortable, high resolution, and repeatable imaging option, particularly for patients with dense breast tissue.

“We are excited to bring our breast imaging technology to Des Moines and to partner with Dr. Tentinger and Innovative Radiology,” said Dr. Raluca Dinu, CEO of QT Imaging Holdings. “This collaboration reflects our shared vision of advancing women’s health by making high-quality, patient-friendly imaging more accessible. We’re also grateful to our distribution partner, NXC Imaging, for facilitating this important connection and supporting the successful deployment of our technology.”

Dr. Tentinger, a respected board-certified radiologist, leads Innovative Radiology with a focus on furthering access to precise imaging and accurate diagnostic assessments to ensure that patients have a clear road map to optimally navigate their health journey. In addition to the newly installed QT Imaging Breast Acoustic CT Scanner, his facility is equipped with a full suite of imaging technologies, including mammography, MRI, CT, ultrasound, and X-ray—ensuring comprehensive diagnostic capabilities under one roof. The addition of QTI’s technology further enhances the clinic’s commitment to offering the latest in imaging innovation.

“Our practice is dedicated to improving diagnostic outcomes while prioritizing patient experience,” said Dr. Tentinger. “The QT Imaging Breast Acoustic CT Scanner allows us to offer a safer, gentler, yet highly detailed breast imaging option that many patients will prefer. We’re proud to be the first in Iowa to offer this technology.”

About QT Imaging Holdings, Inc.

QT Imaging Holdings, Inc. is a public (OTCQB: QTIH) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the company’s website at www.qtimaging.com.

Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.

About Innovative Radiology, Inc.

Innovative Radiology specializes in precision imaging to optimize patient outcomes. Utilizing state-of-the-art imaging equipment, it employs highly skilled radiologists and technologists who provide detailed and timely diagnostic assessments for medical providers, so they are empowered to make confident healthcare decisions for their patients.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as “will,” and “expect,” or the negative thereof or comparable terminology, and include (without limitation) statements regarding the presentation and performance of the QT Imaging Breast Acoustic CT imaging technology, plans for QT Imaging Holdings, new product development and introduction, and product sales growth and projected revenues. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: research results from the use of the QT Imaging Breast Acoustic CT Scanner, the ability of QT Imaging Holdings to sell and deploy the QT Imaging Breast Acoustic CT Scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and “bring to market” plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of QT Imaging Holding’s filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging Holdings as of the date hereof, and QT Imaging Holdings assumes no obligation to update any forward-looking statement.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250515636068/en/

For media inquiries, please contact:

Stas Budagov

Chief Financial Officer

Stas.Budagov@qtimaging.com

Source: QT Imaging Holdings, Inc.